Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review

Objective: For metastatic/recurrent nasopharyngeal carcinoma (NPC) patients, a programmed cell death protein 1 (PD-1) is a controversial option. This meta-analysis aimed to investigate the efficacy and safety of PD-1 inhibitors in patients with metastatic/recurrent NPC. Methods: Electronic databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Le, Ren, Bi, Hu, Rongqiu, Zhang, Huiping, Gou, Haocheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870248/
https://www.ncbi.nlm.nih.gov/pubmed/36699086
http://dx.doi.org/10.3389/fphar.2022.1095734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870248/
https://www.ncbi.nlm.nih.gov/pubmed/36699086
http://dx.doi.org/10.3389/fphar.2022.1095734

Ejemplares similares